Hydroxyurea stimulates the release of ATP from rabbit erythrocytes through an increase in calcium and nitric oxide production

European Journal of Pharmacology

Volumn 645, Issue 1-3, 2010, Pages 32-38

  Raththagala, Madushi ^a   Karunarathne, Welivitya ^a   Kryziniak, Matthew ^a   McCracken, John ^a   Spence, Dana M ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

ATP adenosine triphosphate ; ENOS endothelial nitric oxide synthase ; Hydroxyurea; Nitric oxide; Red cell; Sickle cell

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); CALCIUM ION; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLIBENCLAMIDE; HYDROXYUREA; N(G) NITROARGININE METHYL ESTER;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD FLOW VELOCITY; CONCENTRATION RESPONSE; CYTOLYSIS; DRUG MECHANISM; ENZYME ACTIVITY; ERYTHROCYTE; MALE; NITROSYLATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN SECRETION;

ADENOSINE TRIPHOSPHATE; ANIMALS; CALCIUM; CHEMILUMINESCENT MEASUREMENTS; ERYTHROCYTES; HYDROXYUREA; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RABBITS; SPECTROPHOTOMETRY, ATOMIC;

EID: 77956184649     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.07.012     Document Type: Article

References (46)

1. Athanassiou G., Moutzouri A., Kourakli A., Zoumbos N. Effect of hydroxyurea on the deformability of the red blood cell membrane in patients with sickle cell anemia. Clinical Hemorheology and Microcirculation 2006, 35:291-295.
2. Bateman R.M., Jagger J.E., Sharpe M.D., Ellsworth M.L., Mehta S., Ellis C.G. Erythrocyte deformability is a nitric oxide-mediated factor in decreased capillary density during sepsis. American Journal of Physiology. Heart and Circulatory Physiology 2001, 280:H2848-H2856.
3. Bergfeld G.R., Forrester T. Release of ATP from human erythrocytes in response to a brief period of hypoxia and hypercapnia. Cardiovascular Research 1992, 26:40-47.
4. Bor-Kucukatay M., Wenby R.B., Meiselman H.J., Baskurt O.K. Effects of nitric oxide on red blood cell deformability. American Journal of Physiology. Heart and Circulatory Physiology 2003, 284:H1577-H1584.
5. Cao Z.L., Bell J.B., Mohanty J.G., Nagababu E., Rifkind J.M. Nitrite enhances RBC hypoxic ATP synthesis and the release of ATP into the vasculature: a new mechanism for nitrite-induced vasodilation. American Journal of Physiology. Heart and Circulatory Physiology 2009, 297:H1494-H1503.
6. Carroll J., Raththagala M., Subasinghe W., Baguzis S., Oblak T.D.a., Root P., Spence D. An altered oxidant defense system in red blood cells affects their ability to release nitric oxide-stimulating ATP. Molecular Biosystems 2006, 2:305-311.
7. Charache S., Terrin M.L., Moore R.D., Dover G.J., Barton F.B., Eckert S.V., Mcmahon R.P., Bonds D.R., Orringer E., Jones S., Strayhorn D., Rosse W., Phillips G., Peace D., Johnsontelfair A., Milner P., Kutlar A., Tracy A., Ballas S.K., Allen G.E., Moshang J., Scott B., Steinberg M., Anderson A., Sabahi V., Pegelow C., Temple D., Case E., Harrell R., Childerie S., Embury S., Schmidt B., Davies D., Koshy M., Talischyzahed N., Dorn L., Pendarvis G., Mcgee M., Telfer M., Davis A., Castro O., Finke H., Perlin E., Siteman J., Gascon P., Dipaolo P., Gargiulo S., Eckman J., Bailey J.H., Platt A., Waller L., Ramirez G., Knors V., Hernandez S., Rodriguez E.M., Wilkes E., Vichinsky E., Claster S., Earles A., Kleman K., Mclaughlin K., Swerdlow P., Smith W., Maddox B., Usry L., Brenner A., Williams K., Obrien R., Genther K., Shurin S., Berman B., Chiarucci K., Keverline L., Olivieri N., Shaw D., Lewis N., Bridges K., Tynan B., Winograd C., Bellevue R., Dosik H., Sheikhai M., Ryans P., Souffrant H., Prchal J., Braddock J., Mcardle T., Carlos T., Schmotzer A., Gardner D., Moore R., Dover G., Bergner M., Ewart C., Eckert S., Lent C., Ulrich J., Fishpaw L., Tirado G., Gibson J., Moeller T., Nagel T., Terrin M., Handy C., Harris D., Canner M., Depkin J., Meinert N., Carroll M., Giro R., Karabelas S., Kelly C., Heyman M., Beilinson P., Druskin M., Ellis P., Flood W.A., Kravitz S., Lanzkron S., Lorica V., Moliterno A., Nahum A., Nesbitt J.A., Rosenthal L., Sharfman W., Streiff M., Wachsman M., Bray P., Vandang C., Casella J., Mcguire M., Patrick L., Schaad H., Steiner C., Johnson C., Bank A., Cutter G., Davis C.E., Huntley O., Lessin L., Platt O., Graysecundy M., Bonds D., Reid C., Geller H., Waclawiw M. Effect of hydroxyurea on the frequency of painful crises in sickle-cell-anemia. The New England Journal of Medicine 1995, 332:1317-1322.
8. Cokic V.P., Beleslin-Cokic B.B., Tomic M., Stojilkovic S.S., Noguchi C.T., Schechter A.N. Hydroxyurea induces the eNOS-cGMP pathway in endothelial cells. Blood 2006, 108:184-191.
9. Dietrich H.H., Ellsworth M.L., Sprague R.S., Dacey R.G. Red blood cell regulation of microvascular tone through adenosine triphosphate. American Journal of Physiology. Heart and Circulatory Physiology 2000, 278:H1294-H1298.
10. el-Hazmi M.A., Warsy A.S., al-Momen A., Harakati M. Hydroxyurea for the treatment of sickle cell disease. Acta Haematologica 1992, 88:170-174.
11. Ellsworth M.L., Forrester T., Ellis C.G., Dietrich H.H. The erythrocyte as a regulator of vascular tone. The American Journal of Physiology 1995, 269:H2155-H2161.
12. Ferrari E., Fioravanti M., Patti A.L., Viola C., Solerte S.B. Effects of long-term treatment (4years) with pentoxifylline on haemorheological changes and vascular complications in diabetic patients. Pharmatherapeutica 1987, 5:26-39.
13. Fischer D.J., Torrence N.J., Sprung R.J., Spence D.M. Determination of erythrocyte deformability and its correlation to cellular ATP release using microbore tubing with diameters that approximate resistance vessels in vivo. The Analyst 2003, 128:1163-1168. (Cambridge, U. K.).
14. Genes L.I., Tolan N.V., Hulvey M.K., Martin R.S., Spence D.M. Addressing a vascular endothelium array with blood components using underlying microfluidic channels. Lab on a Chip 2007, 7:1256-1259.
15. Glover R.E., Ivy E.D., Orringer E.P., Maeda H., Mason R.P. Detection of nitrosyl hemoglobin in venous blood in the treatment of sickle cell anemia with hydroxyurea. Molecular Pharmacology 1999, 55:1006-1010.
16. Halsey C., Roberts I.A.G. The role of hydroxyurea in sickle cell disease. British Journal Haematology 2003, 120:177-186.
17. Huang Z., Louderback J.G., King S.B., Ballas S.K., Kim-Shapiro D.B. In vitro exposure to hydroxyurea reduces sickle red blood cell deformability. American Journal of Hematology 2001, 67:151-156.
18. Jiang J., Jordan S.J., Barr D.P., Gunther M.R., Maeda H., Mason R.P. In vivo production of nitric oxide in rats after administration of hydroxyurea. Molecular Pharmacology 1997, 52:1081-1086.
19. Jubelin B.C., Gierman J.L. Erythrocytes may synthesize their own nitric oxide. American Journal of Hypertension 1996, 9:1214-1219.
20. Kaul D.K., Liu X.D., Fabry M.E., Nagel R.L. Impaired nitric oxide-mediated vasodilation in transgenic sickle mouse. American Journal of Physiology. Heart and Circulatory Physiology 2000, 278:H1799-H1806.
21. King S.B. The nitric oxide producing reactions of hydroxyurea. Current Medicinal Chemistry 2003, 10:437-452.
22. King S.B. Nitric oxide production from hydroxyurea. Free Radical Biology & Medicine 2004, 37:737-744.
23. Kirima K., Tsuchiya K., Sei H., Hasegawa T., Shikishima M., Motobayashi Y., Morita K., Yoshizumi M., Tamaki T. Evaluation of systemic blood NO dynamics by EPR spectroscopy: HbNO as an endogenous index of NO. American Journal of Physiology. Heart and Circulatory Physiology 2003, 285:H589-H596.
24. Kleinbongard P., Schulz R., Rassaf T., Lauer T., Dejam A., Jax T., Kumara I., Gharini P., Kabanova S., Ozuyaman B., Schnurch H.G., Godecke A., Weber A.A., Robenek M., Robenek H., Bloch W., Rosen P., Kelm M. Red blood cells express a functional endothelial nitric oxide synthase. Blood 2006, 107:2943-2951.
25. Kleschyov A.L., Wenzel P., Munzel T. Electron paramagnetic resonance (EPR) spin trapping of biological nitric oxide. Journal of Chromatography. B: Analytical Technologies in the Biomedical and Life Sciences 2007, 851:12-20.
26. Korbut R.A., Adamek-Guzik T., Madej J., Korbut R. Endothelial secretogogues and deformability of erythrocytes. Journal of Physiology and Pharmacology 2002, 53:655-665.
27. Kunt T., Schneider S., Pfutzner A., Goitum K., Engelbach M., Schauf B., Beyer J., Forst T. The effect of human proinsulin C-peptide on erythrocyte deformability in patients with type I diabetes mellitus. Diabetologia 1999, 42:465-471.
28. Mack A.K., Kato G.J. Sickle cell disease and nitric oxide: a paradigm shift?. The International Journal of Biochemistry & Cell Biology 2006, 38:1237-1243.
29. McCullough W.T., Collins D.M., Ellsworth M.L. Arteriolar responses to extracellular ATP in striated muscle. The American Journal of Physiology 1997, 272:H1886-H1891.
30. Mesquita R., Picarra B., Saldanha C., Silva J.M.E. Nitric oxide effects on human erythrocytes structural and functional properties - an in vitro study. Clinical Hemorheology and Microcirculation 2002, 27:137-147.
31. Meyer J.A., Froelich J.M., Reid G.E., Karunarathne W.K., Spence D.M. Metal-activated C-peptide facilitates glucose clearance and the release of a nitric oxide stimulus via the GLUT1 transporter. Diabetologia 2008, 51:175-182.
32. Meyer J.A., Subasinghe W., Sima Anders A.F., Keltner Z., Reid G.E., Daleke D.L., Spence D.M. Zinc-activated C-peptide resistance to the type 2 diabetic Erythrocyte is associated with hyperglycemia-induced phosphatidylserine externalization and reversed by metformin. Molecular Biosystems 2009, 5:1157-1162.
33. Nahavandi M., Tavakkoli F., Millis R.M., Wyche M.Q., Habib M.J., Tavakoli N. Effects of hydroxyurea and l-arginine on the production of nitric oxide metabolites in cultures of normal and sickle erythrocytes. Hematology 2006, 11:291-294.
34. Olearczyk J.J., Stephenson A.H., Lonigro A.J., Sprague R.S. NO inhibits signal transduction pathway for ATP release from erythrocytes via its action on heterotrimeric G protein G(i). American Journal of Physiology. Heart and Circulatory Physiology 2004, 287:H748-H754.
35. Pawloski J.R., Hess D.T., Stamler J.S. Impaired vasodilation by red blood cells in sickle cell disease. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:2531-2536.
36. Platt O.S. Hydroxyurea for the treatment of sickle cell anemia. The New England Journal of Medicine 2008, 358:1362-1369.
37. Price A.K., Fischer D.J., Martin R.S., Spence D.M. Deformation-induced release of ATP from erythrocytes in a poly(dimethylsiloxane)-based microchip with channels that mimic resistance vessels. Analytical Chemistry 2004, 76:4849-4855.
38. Rodgers G.P., Dover G.J., Uyesaka N., Noguchi C.T., Schechter A.N., Nienhuis A.W. Augmentation by erythropoietin of the fetal-hemoglobin response to hydroxyurea in sickle cell disease. The New England Journal of Medicine 1993, 328(2):73-80.
39. Sato K., Akaike T., Sawa T., Miyamoto Y., Suga M., Ando M., Maeda H. Nitric oxide generation from hydroxyurea via copper-catalyzed peroxidation and implications for pharmacological actions of hydroxyurea. Japanese Journal of Cancer Research 1997, 88:1199-1204.
40. Fundamentals of Physiology: a Human Perspective 2005, Cengage Learning. 3 ed. L. Sherwood (Ed.).
41. Sprague R.S., Ellsworth M.L., Stephenson A.H., Lonigro A.J. ATP: the red blood cell link to NO and local control of the pulmonary circulation. The American Journal of Physiology 1996, 271:H2717-H2722.
42. Sprague R.S., Ellsworth M.L., Stephenson A.H., Kleinhenz M.E., Lonigro A.J. Deformation-induced ATP release from red blood cells requires CFTR activity. The American Journal of Physiology 1998, 275:H1726-H1732.
43. Sprague R.S., Ellsworth M.L., Stephenson A.H., Kleinhenz M.E., Lonigro A.J. Deformation-induced ATP release from red blood cells requires cystic fibrosis transmembrane conductance regulator activity. The American Journal of Physiology 1998, 275:H1726-H1732.
44. Sprague R.S., Olearczyk J.J., Spence D.M., Stephenson A.H., Sprung R.W., Lonigro A.J. Extracellular ATP signaling in the rabbit lung: erythrocytes as determinants of vascular resistance. The American Journal of Physiology 2003, 285:H693-H700.
45. Sprung R., Sprague R., Spence D. Determination of ATP release from erythrocytes using microbore tubing as a model of resistance vessels in vivo. Analytical Chemistry 2002, 74:2274-2278.
46. Starzyk D., Korbut R., Gryglewski R.J. Effects of nitric oxide and prostacyclin on deformability and aggregability of red blood cells of rats ex vivo and in vitro. Journal of Physiology and Pharmacology 1999, 50:629-637.